Cencora (COR) vs Cellyan Biotechnology (HKPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cencora is the larger company by market cap ($61.32 billion vs $5.0 million), about 12335.5 times the size. Cencora pays a dividend yielding 0.73%, while Cellyan Biotechnology does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | COR | HKPD |
|---|---|---|
| Share price | $321.35 | $0.1008 |
| Market cap | $61.32B | $4.97M |
| 1-day change | +1.29% | -2.80% |
| YTD return | -6.07% | — |
| 1-year return | +2.77% | — |
| 5-year return | +164.68% | — |
| P/E ratio (TTM) | 23.86 | — |
| Forward P/E | 16.23 | — |
| EPS (TTM) | $13.47 | $-0.07 |
| Dividend yield | 0.73% | 0.00% |
| Annual dividend | $2.35 | $0.00 |
| Revenue (latest FY) | $321.33B | — |
| Revenue growth (YoY) | +9.31% | — |
| Net income (latest FY) | $1.55B | — |
| Gross margin | 3.57% | — |
| Operating margin | 0.82% | — |
| Net margin | 0.48% | — |
| 52-week high | $377.54 | $1.72 |
| 52-week low | $244.82 | $0.095 |
| Distance from 52-week high | -14.88% | -94.14% |
| Analyst consensus | buy | — |
| Avg. price target upside | +14.91% | — |
| Average volume | 1.33M | 3.77M |
| Shares outstanding | 190.83M | 42.17M |
| Employees | 47,000 | — |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 12335.5 times larger than Cellyan Biotechnology by market value ($61.32B vs $4.97M).
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
COR vs HKPD FAQ
Which is bigger, Cencora or Cellyan Biotechnology?
Cencora (COR) is larger, with a market capitalization of $61.32B compared with $4.97M for Cellyan Biotechnology (HKPD).
Which pays a higher dividend, Cencora or Cellyan Biotechnology?
Cencora pays a dividend yielding 0.73%, while Cellyan Biotechnology does not currently pay a regular dividend.
Are Cencora and Cellyan Biotechnology in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.